Tsuyoshi Hirata, M., Yuji Uehara, M., Taiki Hakozaki, M., Takayuki Kobayashi, M., Yuto Terashima, M., Kageaki Watanabe, M., . . . Yukio Hosomi, M. Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]. Elsevier.
Chicago Style (17th ed.) CitationTsuyoshi Hirata, MD, MD Yuji Uehara, MD Taiki Hakozaki, MD Takayuki Kobayashi, MD Yuto Terashima, MD Kageaki Watanabe, MD Makiko Yomota, and MD Yukio Hosomi. Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]. Elsevier.
MLA (9th ed.) CitationTsuyoshi Hirata, MD, et al. Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]. Elsevier.